Showing 201-210 of 222 results for "".
- Industry Vet Didier Leclercq Joins Aerolase Leadership Teamhttps://modernaesthetics.com/news/industry-vet-didier-leclercq-joins-aerolase-leadership-team/2472958/Didier Leclercq is Aerolase’s new Vice President of Global Market Development. Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med onc
- Ransomware Alert: Government Advisory Suggests Threat to Healthcare Systemhttps://modernaesthetics.com/news/ransomware-alert-government-advisory-suggests-threat-to-healthcare-system/2473012/A new advisory coauthored by the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services (HHS) warns of the potential for ransomware attacks against hospitals and medical systems. “CI
- Glamour Ranks Best Face Moisturizershttps://modernaesthetics.com/news/glamour-ranks-best-face-moisturizers/2473574/Glamour released its “22 Best Face Moisturizers” list, naming SkinMedica’s HA5 Rejuvenating Hydrator the best overall. “I think my skin actually looks different—in a good way,” one tester said of the SkinMedica product. The monthslong process
- Research Shows Recombinant Pure PDGF Improves Aesthetic Results, Patient Satisfaction Following RF Microneedlinghttps://modernaesthetics.com/news/research-recombinant-pure-pdgf-improves-aesthetic-results-patient-satisfaction-radio-frequency-microneedling/2483898/Research published in the Journal of Cosmetic Dermatology evaluates the efficacy and safety of topical application of pure platelet-derived growth factor (PDGF) compared with standard of care following radiofrequency (RF) microneedling. A prospective, evaluator-blinded, randomize
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glutathio
- Study: Patients Prefer Top-to-Bottom Injection Techniquehttps://modernaesthetics.com/news/study-patients-prefer-top-to-bottom-injection-technique/2473627/Orienting the needle from top to bottom, taking into account migration to the upper lip, led to greater patient satisfaction in a study of lip rejuvenation techniques published in Cureus. Dr. Omer Buhsem conducted a randomized retrospective study of 216 female patients, using a top-to-b
- Will Platysma Prominence Be the Next Nod for BOTOX Cosmetic?https://modernaesthetics.com/news/will-platysma-prominence-be-the-next-nod-for-botox-cosmetic/2473497/Allergan Aesthetics’ BOTOX Cosmetic met all primary and secondary endpoints for the treatment of moderate to severe platysma prominence associated with platysma muscle activity, according to topline results from the second of three Phase 3 studies. The multicenter, randomized
- Cutera Introduces Secret DUOhttps://modernaesthetics.com/news/cutera-introduces-secret-duo/2473490/Cutera, Inc. is launching Secret DUO, a skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. Secret DUO is equipped
- BTL Takes on Music Festival Season With Emfesthttps://modernaesthetics.com/news/btl-takes-on-music-festival-season-with-emfest/2473422/BTL’s Emfest is coming to set to the Pasea Resort and Spa in Huntington Beach, Calif. The event, slated for Aug. 26, 2023, will feature a diverse lineup of music performances. In addition to the musical aspect, Emfest will provide a wide range of wellness activities and
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus